Theradaptive is a company that develops a computational therapeutic delivery platform for clinical indications. It converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers. The company specializes in immuno-oncology, orthopedics, and soft tissue repair.